# 420 with CNW – Texas Grapples with Increasing Marijuana DUI Cases > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/texas-marijuana-dui-laws-challenges-clinical-insights/ > **Published:** 2026-02-28T17:05:58-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T12:01:31-04:00 > **Clinical Summary:** Explore Texas marijuana DUI laws and clinical challenges with THC impairment and medical cannabis driving risks in this detailed overview. --- ✦ New CED Clinical Relevance#62Notable Clinical InterestEmerging findings or policy developments worth monitoring closely. PolicySafetyTHC Why This MattersClinicians prescribing [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) in Texas must counsel patients on impaired driving risks and legal liability, as proposed per se THC limits could criminalize therapeutic users whose blood levels reflect past use rather than current impairment. The pharmacokinetic reality that THC metabolites persist for days after functional impairment resolves presents a critical gap between legal standards and clinical evidence that could expose compliant patients to prosecution. Understanding these regulatory developments is essential for informed consent discussions and for advocating appropriate legal frameworks that protect both public safety and legitimate medical cannabis patients. Clinical Summary Cannabis-impaired driving poses documented public safety risks through THC’s effects on psychomotor function, reaction time, and divided attention, yet establishing a per se blood THC limit for driving enforcement remains scientifically problematic because THC and its metabolites persist in blood for days to weeks after acute intoxication has resolved, with no validated threshold that reliably correlates with functional impairment. Current legislative efforts in Texas to implement per se THC limits for driving could inadvertently criminalize patients using cannabis for legitimate medical purposes who are not acutely impaired, similar to challenges that have emerged in other jurisdictions with comparable laws. Physicians prescribing cannabis should counsel patients that current driving laws may not distinguish between acute impairment and residual THC presence, creating legal liability despite therapeutic use. Standardized objective measures of acute cannabis impairment (such as performance-based field sobriety testing or validated cognitive assessments) would better serve both public safety and the rights of medical cannabis patients. The clinical takeaway is that providers should inform cannabis-using patients about the disconnect between THC blood persistence and actual driving impairment, and advise them to avoid driving during the period of acute effects while acknowledging the legal uncertainty surrounding their protection when using cannabis as a prescribed medication. Dr. Caplan’s Take“The fundamental problem with per se THC limits is that they conflate presence with impairment, which is scientifically indefensible. THC metabolites can remain detectable in blood for weeks after use, particularly in regular medical patients, yet tell us nothing about actual driving ability at the time of testing. We need roadside impairment assessment tools and standardized clinical protocols before we can responsibly criminalize [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in drivers who may be completely sober.” Clinical Perspective Healthcare providers should be aware that establishing per se THC driving limits presents a genuine clinical dilemma, as THC metabolites can remain detectable in blood for days or weeks after use despite complete resolution of impairment, potentially criminalizing patients on legitimate medical [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/). The relationship between blood THC concentration and actual driving impairment is nonlinear and highly variable across individuals due to differences in tolerance, metabolism, and consumption method, making it fundamentally different from alcohol’s more predictable pharmacokinetics. Additionally, current roadside testing lacks the specificity to distinguish between active intoxication and residual metabolites, and many patients are unaware of the legal risks they face when using medically prescribed cannabis before driving. Clinicians should counsel patients on [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) about local DUI laws, advise caution with driving especially during the initial dosing period when impairment is most likely, and consider documenting medical necessity in the 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+420+with+CNW+%26%238211%3B+Texas+Grapples+with+Increasing+Cases+of+Marijuana+DUI+%40drcaplan&url=https%3A%2F%2Finvestingnews.com%2F420-with-cnw-texas-grapples-with-increasing-cases-of-marijuana-dui)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Finvestingnews.com%2F420-with-cnw-texas-grapples-with-increasing-cases-of-marijuana-dui)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+420+with+CNW+%26%238211%3B+Texas+Grapples+with+Increasing+Cases+of+Marijuana+DUI+--+via+%40drcaplan.bsky.social+https%3A%2F%2Finvestingnews.com%2F420-with-cnw-texas-grapples-with-increasing-cases-of-marijuana-dui)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://investingnews.com/420-with-cnw-texas-grapples-with-increasing-cases-of-marijuana-dui](https://investingnews.com/420-with-cnw-texas-grapples-with-increasing-cases-of-marijuana-dui) Further Reading Evidence Watch[`Cannabinoid Clinical Trials: CBD Cortical Excitability Study`](https://cedclinic.com/cannabidiol-lacks-intrinsic-anti-epileptic-properties-trial/) CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 10, 2026](https://cedclinic.com/dea-scheduling-synthetic-opioids-regulatory-updates-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Virginia officials launch campaign against driving under influence of marijuana – WWBT](https://cedclinic.com/virginia-marijuana-impaired-driving-campaign/) Learn about Virginia's efforts to combat marijuana-impaired driving and how it compares to Texas regulations. [Read More](https://cedclinic.com/virginia-marijuana-impaired-driving-campaign/) [Medical Marijuana & Driving Performance](https://cedclinic.com/medical-marijuana-driving-performance/) Explore clinical evidence on how [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) affects driving performance and safety. [Explore Insights](https://cedclinic.com/medical-marijuana-driving-performance/) [Drivers who test positive for medicinal cannabis could get behind the wheel – YouTube](https://cedclinic.com/medical-marijuana-driving-performance/) Watch a discussion on the complexities of medicinal [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and driving laws. [Watch Now](https://cedclinic.com/medical-marijuana-driving-performance/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).